Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD

<b>Background/Objectives:</b> Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with cardiometabolic risk. Although studies have shown that estradiol positively contributes to energy metabolism via estrogen receptor alpha (ERα), its role specifically in the l...

Full description

Saved in:
Bibliographic Details
Main Authors: Ester S. Alves, Jessica D. M. Santos, Alessandra G. Cruz, Felipe N. Camargo, Carlos H. Z. Talarico, Anne R. M. Santos, Carlos A. A. Silva, Henrique J. N. Morgan, Sandro L. Matos, Layanne C. C. Araujo, João Paulo Camporez
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pathophysiology
Subjects:
Online Access:https://www.mdpi.com/1873-149X/32/1/1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849342645905653760
author Ester S. Alves
Jessica D. M. Santos
Alessandra G. Cruz
Felipe N. Camargo
Carlos H. Z. Talarico
Anne R. M. Santos
Carlos A. A. Silva
Henrique J. N. Morgan
Sandro L. Matos
Layanne C. C. Araujo
João Paulo Camporez
author_facet Ester S. Alves
Jessica D. M. Santos
Alessandra G. Cruz
Felipe N. Camargo
Carlos H. Z. Talarico
Anne R. M. Santos
Carlos A. A. Silva
Henrique J. N. Morgan
Sandro L. Matos
Layanne C. C. Araujo
João Paulo Camporez
author_sort Ester S. Alves
collection DOAJ
description <b>Background/Objectives:</b> Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with cardiometabolic risk. Although studies have shown that estradiol positively contributes to energy metabolism via estrogen receptor alpha (ERα), its role specifically in the liver is not defined. Therefore, this study aimed to evaluate the effects of ERα overexpression, specifically in the liver in mice fed a high-fat diet (HFD). <b>Methods:</b> Male C57BL/6J mice were divided into four groups, vehicle fed with regular chow (RC) (RC-Vehicle); vehicle fed an HFD (HFD-Vehicle); AAV-treated fed with RC (RC-AAV); and AAV-treated fed an HFD (HFD-AAV), for 6 weeks (8–10 mice per group). AAV was administered intravenously to induce ERα overexpression. <b>Results:</b> We demonstrate that overexpression of ERα in RC-fed mice reduces body fat (28%). These mice show increased oxygen consumption in cultured primary hepatocytes, both in basal (19%) and maximal respiration (34%). In HFD-fed mice, we showed a decrease in hepatic TAG content (43%) associated with improved hepatic insulin sensitivity (145%). <b>Conclusions:</b> From this perspective, our results prove that hepatic ERα signaling is responsible for some of the metabolic protective effects of estrogen in mice. Overexpression of ERα improves hepatocyte mitochondrial function, consequently reducing hepatic lipid accumulation and protecting animals from hepatic steatosis and hepatic insulin resistance. Further investigations will be needed to determine the exact molecular mechanism by which ERα improves hepatic metabolic health.
format Article
id doaj-art-df2be53dc5f24c1ca94fa05248197f06
institution Kabale University
issn 1873-149X
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pathophysiology
spelling doaj-art-df2be53dc5f24c1ca94fa05248197f062025-08-20T03:43:20ZengMDPI AGPathophysiology1873-149X2025-01-01321110.3390/pathophysiology32010001Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLDEster S. Alves0Jessica D. M. Santos1Alessandra G. Cruz2Felipe N. Camargo3Carlos H. Z. Talarico4Anne R. M. Santos5Carlos A. A. Silva6Henrique J. N. Morgan7Sandro L. Matos8Layanne C. C. Araujo9João Paulo Camporez10Department of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, BrazilSuperior Institute of Biomedical Sciences, State University of Ceara, Fortaleza 60714-903, BrazilDepartment of Physiology, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirão Preto 14049-900, Brazil<b>Background/Objectives:</b> Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with cardiometabolic risk. Although studies have shown that estradiol positively contributes to energy metabolism via estrogen receptor alpha (ERα), its role specifically in the liver is not defined. Therefore, this study aimed to evaluate the effects of ERα overexpression, specifically in the liver in mice fed a high-fat diet (HFD). <b>Methods:</b> Male C57BL/6J mice were divided into four groups, vehicle fed with regular chow (RC) (RC-Vehicle); vehicle fed an HFD (HFD-Vehicle); AAV-treated fed with RC (RC-AAV); and AAV-treated fed an HFD (HFD-AAV), for 6 weeks (8–10 mice per group). AAV was administered intravenously to induce ERα overexpression. <b>Results:</b> We demonstrate that overexpression of ERα in RC-fed mice reduces body fat (28%). These mice show increased oxygen consumption in cultured primary hepatocytes, both in basal (19%) and maximal respiration (34%). In HFD-fed mice, we showed a decrease in hepatic TAG content (43%) associated with improved hepatic insulin sensitivity (145%). <b>Conclusions:</b> From this perspective, our results prove that hepatic ERα signaling is responsible for some of the metabolic protective effects of estrogen in mice. Overexpression of ERα improves hepatocyte mitochondrial function, consequently reducing hepatic lipid accumulation and protecting animals from hepatic steatosis and hepatic insulin resistance. Further investigations will be needed to determine the exact molecular mechanism by which ERα improves hepatic metabolic health.https://www.mdpi.com/1873-149X/32/1/1insulin actionestrogen signalinghepatic insulin resistanceMASLD
spellingShingle Ester S. Alves
Jessica D. M. Santos
Alessandra G. Cruz
Felipe N. Camargo
Carlos H. Z. Talarico
Anne R. M. Santos
Carlos A. A. Silva
Henrique J. N. Morgan
Sandro L. Matos
Layanne C. C. Araujo
João Paulo Camporez
Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
Pathophysiology
insulin action
estrogen signaling
hepatic insulin resistance
MASLD
title Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
title_full Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
title_fullStr Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
title_full_unstemmed Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
title_short Hepatic Estrogen Receptor Alpha Overexpression Protects Against Hepatic Insulin Resistance and MASLD
title_sort hepatic estrogen receptor alpha overexpression protects against hepatic insulin resistance and masld
topic insulin action
estrogen signaling
hepatic insulin resistance
MASLD
url https://www.mdpi.com/1873-149X/32/1/1
work_keys_str_mv AT estersalves hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT jessicadmsantos hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT alessandragcruz hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT felipencamargo hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT carloshztalarico hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT annermsantos hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT carlosaasilva hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT henriquejnmorgan hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT sandrolmatos hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT layanneccaraujo hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld
AT joaopaulocamporez hepaticestrogenreceptoralphaoverexpressionprotectsagainsthepaticinsulinresistanceandmasld